IncellDx, Inc. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers.
Recognizing every cell tells a story we are dedicated to revolutionizing healthcare one cell at a time. Combining proprietary molecular diagnostics with cellular analysis, we offer diagnostic, prognostic and therapeutic clinical information for physicians to make more informed clinical decisions.
HPV OncoTect 3Dx™
More than 450,000 new cases of cervical cancer are diagnosed each year. Our CE-IVD HPV OncoTect 3Dx™ for in vitro diagnostics is a unique quantative cell based assay that measures both mRNA E6 and E7.
The First Diagnostic Test for Long COVID Will Formally Launch in Europe in September
The IncellDx incellKINE Long COVID In Vitro Diagnostic Receives European CE Marking for Its In Vitro Diagnostic (IVD) for Long COVID